Glutathione trisulfide (GSSSG) in neuroprotection
AssigneeThe General Hospital Corporation
InventorsFumito Ichinose, Eizo Marutani
Life of this patent
Estimating the term…
Abstract
Methods for the use of glutathione trisulfide (GSSSG) in neuroprotection, e.g., in neurodegenerative diseases and to reduce the risk of ischemic injury. The methods can be used, e.g., to reduce risk of injury to brain, spinal cord, and peripheral nerves from ischemia or low blood flow states possibly caused by surgery, trauma, and other conditions that decrease/impair blood flow and or oxygen delivery to the nervous system.
Claims5
A method for the treatment, or reduction of risk, of a disorder associated with neurodegeneration in a subject, the method comprising administering a therapeutically or prophylactically effective amount of a composition comprising Glutathione Trisulfide (GSSSG) and saline to a subject in need thereof, wherein the disorder is post-ischemic neuronal death.
Dependencies are inferred from the claim text.